Silva, A.C.; Costa, M.P.; Zacaron, T.M.; Ferreira, K.C.B.; Braz, W.R.; Fabri, R.L.; Frézard, F.J.G.; Pittella, F.; Tavares, G.D.
The Role of Inhaled Chitosan-Based Nanoparticles in Lung Cancer Therapy. Pharmaceutics 2024, 16, 969.
https://doi.org/10.3390/pharmaceutics16080969
AMA Style
Silva AC, Costa MP, Zacaron TM, Ferreira KCB, Braz WR, Fabri RL, Frézard FJG, Pittella F, Tavares GD.
The Role of Inhaled Chitosan-Based Nanoparticles in Lung Cancer Therapy. Pharmaceutics. 2024; 16(8):969.
https://doi.org/10.3390/pharmaceutics16080969
Chicago/Turabian Style
Silva, Allana Carvalho, Mirsiane Pascoal Costa, Thiago Medeiros Zacaron, Kézia Cristine Barbosa Ferreira, Wilson Rodrigues Braz, Rodrigo Luiz Fabri, Frédéric Jean Georges Frézard, Frederico Pittella, and Guilherme Diniz Tavares.
2024. "The Role of Inhaled Chitosan-Based Nanoparticles in Lung Cancer Therapy" Pharmaceutics 16, no. 8: 969.
https://doi.org/10.3390/pharmaceutics16080969
APA Style
Silva, A. C., Costa, M. P., Zacaron, T. M., Ferreira, K. C. B., Braz, W. R., Fabri, R. L., Frézard, F. J. G., Pittella, F., & Tavares, G. D.
(2024). The Role of Inhaled Chitosan-Based Nanoparticles in Lung Cancer Therapy. Pharmaceutics, 16(8), 969.
https://doi.org/10.3390/pharmaceutics16080969
